- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03613974
Minimum Anaesthesia Concentration of Lidocaine Required for Sciatic Popliteal Block
November 13, 2018 updated by: Ahmad Muhammad Taha, Healthpoint Hospital
Successful Popliteal Block Using Lidocaine; What is the Minimum Effective Anesthesia Concentration (MEAC90)
using a biased-coin design up-down sequential method, different concentration of lidocaine will be used for popliteal block After 45 successful block (positive response), the data will be used to calculate the minimum lidocaine concentration that can result in successful popliteal block in 90% of patients
Study Overview
Detailed Description
The response of a patient determined the lidocaine concentration given to the next patient (a biased-coin design up-down sequential method).
If a patient had a negative response, the lidocaine concentration was increased by 0.1% w/v in the next patient.
If a patient had a positive response, the next patient was randomized to receive the same lidocaine concentration (with probability of 0.89), or to receive a concentration 0.1% w/v less (with probability of 0.11).
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- orthopedic foot or ankle surgery
- day case surgery
Exclusion Criteria: patients
- <18y,
- ASA class greater >III,
- obese (BMI >30),
- patients with low body weight, who required lidocaine dose is of more than 4.5mg.kg-1
- peripheral neuropathy,
- motor weakness,
- infection at the injection site
- any contraindications for medications in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: lidocaine concentraion
the popliteal block will be performed (once) in all patients using 20 ml of lidoacine.
The response of a patient determined the lidocaine concentration given to the next patient (a biased-coin design up-down sequential method).
If a patient had a negative response (failed block), the lidocaine concentration was increased by 0.1% w/v in the next patient.
If a patient had a positive response (successful block), the next patient was randomized to receive the same lidocaine concentration (with probability of 0.89), or to receive a concentration 0.1% w/v less (with probability of 0.11).
|
patients will receive different lidocaine concentrations
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
successful popliteal block (positive response)
Time Frame: 30 min to 3 hour after the block
|
Sensory block will be assessed using pinprick sensation. Complete sensory block = unable to recognize pinprick sensation. Intra-operative pain will be assessed using Visual Analogue Scale (VAS) 0 = No pain, 10 = Worst imaginable pain. Successful block = complete sensory block + pain free surgery (VAS = 0). |
30 min to 3 hour after the block
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
motor block
Time Frame: 30 min after the block
|
degree of motor weakness
|
30 min after the block
|
motor recovery
Time Frame: 3 hours till full recovery
|
complete recover of the motor power
|
3 hours till full recovery
|
analgesic duration
Time Frame: few hours after block
|
requesting painkiller
|
few hours after block
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
December 15, 2018
Primary Completion (Anticipated)
March 15, 2019
Study Completion (Anticipated)
March 31, 2019
Study Registration Dates
First Submitted
July 20, 2018
First Submitted That Met QC Criteria
August 2, 2018
First Posted (Actual)
August 3, 2018
Study Record Updates
Last Update Posted (Actual)
November 14, 2018
Last Update Submitted That Met QC Criteria
November 13, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
- Healthpoint Hospital
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthopedic Procedures
-
Centre Hospitalier Universitaire de NiceNot yet recruitingOrthopedic Procedures | General SurgeryFrance
-
Instituto de Assistencia Medica ao Servidor Publico...RecruitingHemodynamic Monitoring | Orthopedic ProceduresBrazil
-
Rambam Health Care CampusCompletedOrthopedic Procedures, Tranexamic Acid
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBlood Transfusion | Orthopedic Surgery | Orthopedic Procedures | Mammaplasty | Cardiovascular Surgical Procedures | Blood Transfusion, Autologous
-
Asan Medical CenterCompletedOrthopedic Procedures | Remimazolam | SedativesKorea, Republic of
-
State University of New York - Upstate Medical...Zimmer BiometCompletedOrthopedic Procedures | Spinal FusionUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBlood Transfusion | Orthopedic Surgery | Orthopedic Procedures | Cardiovascular Surgical Procedure | Blood Transfusion, Autologous
-
Asan Medical CenterCompletedOrthopedic Procedures | Anesthesia, Spinal | Remimazolam | SedativesKorea, Republic of
-
Yonsei UniversityRecruitingOrthopedic Surgery | Urologic Surgical Procedures | Bone Marrow ExaminationKorea, Republic of
-
Rutgers, The State University of New JerseyWithdrawnOrthopedic/Podiatry ProceduresUnited States
Clinical Trials on Lidocaine
-
Ohio State UniversityCompleted
-
Khon Kaen UniversityNot yet recruitingIntubation | Hemodynamics | Laryngoscopy | Neurosurgery | LidocaineThailand
-
Aswan University HospitalUnknown
-
Benha UniversityCompletedPostcesarean Pain Relief
-
McMaster UniversitySt. Joseph's Healthcare HamiltonWithdrawnIntravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel SurgeryBariatric Surgery Candidate
-
Scilex Pharmaceuticals, Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed
-
Oregon Health and Science UniversityCompleted
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownPostoperative PainKorea, Republic of
-
Hopital FochCompleted